Royalty Pharma plc (RPRX)

Royalty Pharma Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec 20, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	14,682	12,497	17,432	17,116	19,426	-
Market Cap Growth	4.05%	-28.31%	1.85%	-11.89%	-	-
Enterprise Value	21,291	21,132	27,333	26,687	28,409	-
Last Close Price	24.92	27.24	37.36	37.00	45.72	-
PE Ratio	9.76	11.01	407.00	27.62	39.23	-
Forward PE	5.97	7.47	10.32	13.00	19.16	-
PS Ratio	4.93	5.31	7.79	7.48	9.15	-
PB Ratio	1.62	1.24	1.83	1.67	1.96	-
P/TBV Ratio	1.85	1.92	3.11	2.97	4.06	-
P/FCF Ratio	5.25	4.18	8.13	8.48	9.55	-
P/OCF Ratio	5.25	4.18	8.13	8.48	9.55	-
PEG Ratio	1.60	2.65	0.94	1.12	1.97	-
EV/Sales Ratio	9.40	8.98	12.22	11.66	13.39	-
EV/EBITDA Ratio	-	14.11	29.44	18.36	16.87	-
EV/EBIT Ratio	13.79	14.16	29.62	18.65	17.11	-
EV/FCF Ratio	7.61	7.07	12.75	13.23	13.96	-
Debt / Equity Ratio	0.74	0.61	0.75	0.69	0.59	1.02
Debt / EBITDA Ratio	-	4.10	7.66	4.88	3.46	2.37
Debt / FCF Ratio	2.72	2.05	3.32	3.52	2.86	3.76
Asset Turnover	0.13	0.14	0.13	0.14	0.15	0.15
Quick Ratio	1.53	7.87	2.11	16.77	8.73	2.50
Current Ratio	1.54	7.90	2.19	16.81	8.76	2.50
Return on Equity (ROE)	17.28%	17.34%	2.33%	12.32%	21.23%	46.04%
Return on Assets (ROA)	5.69%	5.62%	3.36%	5.33%	7.29%	13.77%
Return on Capital (ROIC)	5.75%	5.68%	3.39%	5.41%	7.38%	13.97%
Earnings Yield	7.80%	9.08%	0.25%	3.62%	5.02%	-
FCF Yield	19.06%	23.91%	12.30%	11.79%	10.47%	-
Dividend Yield	3.37%	2.94%	2.03%	1.84%	0.66%	-
Payout Ratio	32.89%	31.58%	778.21%	46.02%	40.80%	31.48%
Buyback Yield / Dilution	-33.46%	-37.66%	-5.59%	-10.48%	-	-
Total Shareholder Return	-30.09%	-34.72%	-3.55%	-8.64%	0.66%	-

Source: S&P Capital IQ. Standard template. Financial Sources.